Carson Wealth (CWM LLC)’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.5M | Sell |
114,116
-1,405
| -1% | -$65.5K | 0.01% | 774 |
|
|
2025
Q4 | $5.6M | Sell |
115,521
-714
| -0.6% | -$35.4K | 0.02% | 737 |
|
|
2025
Q3 | $5.49M | Buy |
116,235
+2,910
| +3% | +$140K | 0.02% | 673 |
|
|
2025
Q2 | $5.47M | Buy |
113,325
+4,815
| +4% | +$246K | 0.02% | 559 |
|
|
2025
Q1 | $6.02M | Sell |
108,510
-4,631
| -4% | -$251K | 0.02% | 472 |
|
|
2024
Q4 | $5.46M | Sell |
113,141
-9,427
| -8% | -$479K | 0.02% | 455 |
|
|
2024
Q3 | $7.06M | Sell |
122,568
-9,561
| -7% | -$516K | 0.03% | 372 |
|
|
2024
Q2 | $6.41M | Sell |
132,129
-458
| -0.3% | -$22.1K | 0.03% | 372 |
|
|
2024
Q1 | $6.44M | Sell |
132,587
-2,240
| -2% | -$109K | 0.03% | 372 |
|
|
2023
Q4 | $6.71M | Sell |
134,827
-3,323
| -2% | -$162K | 0.04% | 347 |
|
|
2023
Q3 | $7.41M | Sell |
138,150
-11,766
| -8% | -$627K | 0.05% | 290 |
|
|
2023
Q2 | $8.08M | Sell |
149,916
-16,082
| -10% | -$865K | 0.05% | 264 |
|
|
2023
Q1 | $9.03M | Sell |
165,998
-5,370
| -3% | -$261K | 0.06% | 230 |
|
|
2022
Q4 | $8.3M | Buy |
171,368
+2,190
| +1% | +$96.1K | 0.06% | 224 |
|
|
2022
Q3 | $6.43M | Buy |
169,178
+8,382
| +5% | +$374K | 0.05% | 250 |
|
|
2022
Q2 | $8.04M | Buy |
160,796
+4,381
| +3% | +$233K | 0.06% | 228 |
|
|
2022
Q1 | $8.03M | Buy |
156,415
+4,476
| +3% | +$231K | 0.06% | 237 |
|
|
2021
Q4 | $7.61M | Buy |
+151,939
| New | +$7.52M | 0.05% | 253 |
|
|
2021
Q2 | $8.17M | Hold |
155,230
| – | – | 0.07% | 224 |
|
|
2021
Q1 | $8.17M | Hold |
155,230
| – | – | 0.07% | 224 |
|
|
2020
Q4 | $8.17M | Hold |
155,230
| – | – | 0.07% | 224 |
|
|
2020
Q3 | $8.17M | Hold |
155,230
| – | – | 0.07% | 224 |
|
|
2020
Q2 | $8.17M | Hold |
155,230
| – | – | 0.07% | 224 |
|
|
2020
Q1 | $8.17M | Hold |
155,230
| – | – | 0.07% | 224 |
|
|
2019
Q4 | $8.17M | Hold |
155,230
| – | – | 0.07% | 224 |
|
|
2019
Q3 | $8.17M | Hold |
155,230
| – | – | 0.07% | 224 |
|
|
2019
Q2 | $8.17M | Hold |
155,230
| – | – | 0.07% | 224 |
|
|
2019
Q1 | $8.17M | Buy |
155,230
+126,713
| +444% | +$5.43M | 0.07% | 224 |
|
|
2018
Q4 | $1.24M | Buy |
28,517
+22,246
| +355% | +$981K | 0.03% | 342 |
|
|
2018
Q3 | $280K | Buy |
6,271
+6,051
| +2,750% | +$258K | 0.01% | 454 |
|
|
2018
Q2 | $9K | Buy |
220
+160
| +267% | +$6.3K | ﹤0.01% | 1038 |
|
|
2018
Q1 | $2K | Sell |
60
-44
| -42% | -$1.83K | ﹤0.01% | 1203 |
|
|
2017
Q4 | $4K | Sell |
104
-230
| -69% | -$10.6K | ﹤0.01% | 1155 |
|
|
2017
Q3 | $17K | Buy |
334
+284
| +568% | +$13.7K | ﹤0.01% | 757 |
|
|
2017
Q2 | $2K | Buy |
+50
| New | +$2.39K | ﹤0.01% | 1031 |
|
|
2016
Q4 | – | Sell |
-827
| Closed | -$32K | – | 1175 |
|
|
2016
Q3 | $32K | Buy |
+827
| New | +$33.2K | ﹤0.01% | 491 |
|
|
2016
Q1 | – | Sell |
-158
| Closed | -$7K | – | 809 |
|
|
2015
Q4 | $7K | Sell |
158
-518
| -77% | -$23.8K | ﹤0.01% | 498 |
|
|
2015
Q3 | $32K | Buy |
+676
| New | +$34.4K | ﹤0.01% | 325 |
|
Other funds holding SNY
MIP
Carson Wealth (CWM LLC)'s SNY Position: Q1 2026 in Review
Carson Wealth (CWM LLC) reduced its Sanofi (SNY) stake by 1.2% in Q1 2026, selling an estimated $65.5K and leaving 114,116 shares worth $5.5M. The position accounts for 0.01% of the portfolio, ranked #774.
Carson Wealth (CWM LLC) first reported a position in SNY in Q3 2015 and has held it in 38 quarters since. The position peaked at $9.03M in Q1 2023. 745 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Carson Wealth (CWM LLC) held 114,116 shares of Sanofi worth $5.5M as of Q1 2026.
- Carson Wealth (CWM LLC) sold 1,405 Sanofi shares in Q1 2026, an estimated $65.5K.
- Sanofi made up 0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #774 holding.
- Carson Wealth (CWM LLC) first reported a position in Sanofi in Q3 2015 and has held it in 38 quarters since.
- Carson Wealth (CWM LLC)'s Sanofi position peaked at $9.03M in Q1 2023.
- 745 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.